rs114849139

Variant summary

Our verdict is Benign. Variant got -11 ACMG points: 2P and 13B. PM1BP4_StrongBP6BS1BS2

The NM_004646.4(NPHS1):ā€‹c.2869G>Cā€‹(p.Val957Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000648 in 1,614,168 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.00072 ( 4 hom., cov: 32)
Exomes š‘“: 0.00064 ( 9 hom. )

Consequence

NPHS1
NM_004646.4 missense

Scores

6
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:6

Conservation

PhyloP100: 3.23
Variant links:
Genes affected
NPHS1 (HGNC:7908): (NPHS1 adhesion molecule, nephrin) This gene encodes a member of the immunoglobulin family of cell adhesion molecules that functions in the glomerular filtration barrier in the kidney. The gene is primarily expressed in renal tissues, and the protein is a type-1 transmembrane protein found at the slit diaphragm of glomerular podocytes. The slit diaphragm is thought to function as an ultrafilter to exclude albumin and other plasma macromolecules in the formation of urine. Mutations in this gene result in Finnish-type congenital nephrosis 1, characterized by severe proteinuria and loss of the slit diaphragm and foot processes.[provided by RefSeq, Oct 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -11 ACMG points.

PM1
In a domain Fibronectin type-III (size 95) in uniprot entity NPHN_HUMAN there are 5 pathogenic changes around while only 1 benign (83%) in NM_004646.4
BP4
Computational evidence support a benign effect (MetaRNN=0.018834054).
BP6
Variant 19-35839554-C-G is Benign according to our data. Variant chr19-35839554-C-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 225423.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Benign=3, Uncertain_significance=3}. Variant chr19-35839554-C-G is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population eas. gnomad4_exome allele frequency = 0.000641 (937/1461886) while in subpopulation EAS AF= 0.0184 (729/39700). AF 95% confidence interval is 0.0173. There are 9 homozygotes in gnomad4_exome. There are 474 alleles in male gnomad4_exome subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NPHS1NM_004646.4 linkuse as main transcriptc.2869G>C p.Val957Leu missense_variant 21/29 ENST00000378910.10 NP_004637.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NPHS1ENST00000378910.10 linkuse as main transcriptc.2869G>C p.Val957Leu missense_variant 21/291 NM_004646.4 ENSP00000368190 P2O60500-1
NPHS1ENST00000353632.6 linkuse as main transcriptc.2869G>C p.Val957Leu missense_variant 21/285 ENSP00000343634 A2O60500-2

Frequencies

GnomAD3 genomes
AF:
0.000723
AC:
110
AN:
152164
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000579
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0137
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.00106
AC:
267
AN:
251432
Hom.:
0
AF XY:
0.000949
AC XY:
129
AN XY:
135900
show subpopulations
Gnomad AFR exome
AF:
0.000492
Gnomad AMR exome
AF:
0.0000867
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0116
Gnomad SAS exome
AF:
0.000980
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000615
Gnomad OTH exome
AF:
0.000815
GnomAD4 exome
AF:
0.000641
AC:
937
AN:
1461886
Hom.:
9
Cov.:
32
AF XY:
0.000652
AC XY:
474
AN XY:
727244
show subpopulations
Gnomad4 AFR exome
AF:
0.000149
Gnomad4 AMR exome
AF:
0.0000894
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0184
Gnomad4 SAS exome
AF:
0.00107
Gnomad4 FIN exome
AF:
0.0000187
Gnomad4 NFE exome
AF:
0.0000351
Gnomad4 OTH exome
AF:
0.00111
GnomAD4 genome
AF:
0.000716
AC:
109
AN:
152282
Hom.:
4
Cov.:
32
AF XY:
0.000846
AC XY:
63
AN XY:
74454
show subpopulations
Gnomad4 AFR
AF:
0.000578
Gnomad4 AMR
AF:
0.0000654
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.0135
Gnomad4 SAS
AF:
0.00228
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.000506
Hom.:
1
Bravo
AF:
0.000627
ExAC
AF:
0.00119
AC:
144
Asia WGS
AF:
0.00837
AC:
29
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Finnish congenital nephrotic syndrome Uncertain:2Benign:2
Uncertain significance, criteria provided, single submitterreference populationSoonchunhyang University Bucheon Hospital, Soonchunhyang University Medical CenterMar 18, 2016- -
Likely benign, criteria provided, single submitterclinical testingCounsylDec 15, 2017- -
Benign, no assertion criteria providedclinical testingNatera, Inc.Oct 05, 2020- -
Uncertain significance, criteria provided, single submitterclinical testingPars Genome LabMay 18, 2021- -
not specified Benign:2
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Apr 14, 2016- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 30, 2024- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024NPHS1: PM5, BP4, BS1 -
Congenital nephrotic syndrome Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 28, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.15
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Benign
0.26
T;.
Eigen
Uncertain
0.31
Eigen_PC
Uncertain
0.24
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Benign
0.77
T;T
MetaRNN
Benign
0.019
T;T
MetaSVM
Benign
-0.57
T
MutationAssessor
Benign
1.3
L;L
MutationTaster
Benign
0.90
D;D
PrimateAI
Benign
0.46
T
PROVEAN
Benign
-2.3
N;N
REVEL
Benign
0.28
Sift
Uncertain
0.0060
D;D
Sift4G
Uncertain
0.029
D;T
Polyphen
1.0
D;.
Vest4
0.79
MutPred
0.86
Gain of loop (P = 0.1069);Gain of loop (P = 0.1069);
MVP
0.80
MPC
0.33
ClinPred
0.043
T
GERP RS
4.3
Varity_R
0.30
gMVP
0.55

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs114849139; hg19: chr19-36330456; API